drugset / Trial / NCT02465645

To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.

NCT02465645

RandomizedParallel-groupOpen-labelTreatment

Summary

After successful screening of patients based on inclusion criteria, we will measure the baseline Hepatic Venous Pressure Gradient. At day 1 patients will undergo complete blood investigation including complete haemogram, kidney function test, liver function test, prothrombin time, AFP (Alfa Feto Protein) level, chest x ray, ultrasonography, fibroscan. Routine complete physical examination will be done.

Timeline

Start
2015-06-01
Primary completion
2017-01-31
Completion
2017-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 40 mg Oral
Comparator Carvedilol Other / unclassified 12.5 mg Oral

Indications